inPractice® - Dolutegravir

Agents Used in Antiretroviral Therapy

Authors: Philip Grant, MD (More Info)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 9/10/19 (What's New)

Summary

Dolutegravir is indicated in combination with other antiretroviral agents for treatment of HIV infection in adults and children weighing ≥ 30 kg^{[FDA Dolutegravir]}
Dolutegravir is coformulated as part of 2 complete regimens for HIV treatment
- Abacavir/dolutegravir/lamivudine: indicated for treatment-naive and treatment-experienced patients

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Initial Antiretroviral Therapy, Special Populations, Treatment Complications